Transparency of payments and transfers of value

Medicines Australia is a strong advocate for transparency of payments and other transfers of value provided by the Australian medicines industry to health consumer organisations and healthcare professionals. The purpose of disclosure of payments and other activities is to demonstrate our ongoing commitment to this endeavour. It is our hope that this disclosure will help the general public to better understand the nature and extent of programs we support in the interest of increasing quality use of medicines, advancing patient care and supporting our local communities.

For this reason, and to ensure continued public trust in these relationships, the Code of Conduct includes requirements for reporting of payments and benefits to healthcare professionals (e.g. speaker fees, consultant fees, and advisory board member fees) and greater disclosure of the nature of our relationships with health consumer organisations.

To access the new reports for payments and transfers of value made to healthcare professionals please click here (please follow link)

Refer to the table below for the transparency reporting transition plan, which reflects the updates introduced in Edition 20 of the Code of Conduct.